Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06362980
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-03-28
Brief Title:
A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations
Sponsor:
National Cancer Center China
Organization:
National Cancer Center China
Organization Data
Organization:
National Cancer Center China
Class:
OTHER
Study ID:
BPI-1178-IIT01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Center China
Lead Sponsor Class:
OTHER
Responsible Party:
Puyuan Xing
Responsible Party Title:
Chief Medical Officer
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
National Cancer Center China
Old Name:
None
Old Organization:
None